With the federal government’s negotiation of prescription prices with drug companies about to get underway, amicus curiae briefs filed in suits seeking to overturn the program are providing a preview of the coming legal battle.

A plan to negotiate prices of prescription drugs covered under Medicare is facing multiple lawsuits from drugmakers, including at least four cases in New Jersey.